Syndax Pharmaceuticals
Cancer Therapeutics Developer
Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumorsFounded in 2005
Homepage: http://www.syndax.com
Total money raised: $9M
Headquarters
02451 460 Totten Pond RoadSuite 650
Waltham
USA MA
Phone: 781.419.1400
Updated on Apr 18, 2012
Syndax Pharmaceuticals at CrunchBase
Arlene M. Morris CEOSyndax Pharmaceuticals at CrunchBase
Joanna C. Horobin President
Artthur M. Pappas Member of Board
Past
March, 2010
Syndax Pharmaceuticals raised $9M in a Series A round from Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures, and Pappas Ventures
Syndax Pharmaceuticals, Inc.: Series A $9M 
onbiovc.com
2005
Syndax Pharmaceuticals was founded in 2005